Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial.
about
Clinical uses of melatonin in pediatricsA review of complementary and alternative treatments for autism spectrum disordersThe neurology of autism spectrum disordersMelatonin Treatment in Children with Developmental DisabilitiesAutism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectivesAdvances in the research of melatonin in autism spectrum disorders: literature review and new perspectivesThe melatonin receptor agonist ramelteon effectively treats insomnia and behavioral symptoms in autistic disorderBehavioral parent training to address sleep disturbances in young children with autism spectrum disorder: a pilot trialDietary Sources and Bioactivities of MelatoninDisruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders.Melatonin in children with autistic spectrum disorders: recent and practical data.Autism spectrum features in Smith-Magenis syndrome.ASD: Psychopharmacologic Treatments and Neurophysiologic Underpinnings.Common neurological co-morbidities in autism spectrum disorders.The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders.Influence of sleep disorders on the behavior of individuals with autism spectrum disorder.Circadian Rhythms of Oxidative Stress Markers and Melatonin Metabolite in Patients with Xeroderma Pigmentosum Group A.Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular SA brief primer on sleep for pediatric and child clinical neuropsychologistsPotency of pre-post treatment of coenzyme Q10 and melatonin supplement in ameliorating the impaired fatty acid profile in rodent model of autismDissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of MelatoninTreatment of Autism Spectrum Disorder in Children and Adolescents.Complementary and alternative medicine for autism spectrum disorders: rationale, safety and efficacy.What's in the pipeline? Drugs in development for autism spectrum disorder.Paediatric Off-Label Use of Melatonin--A Register Linkage Study between the Norwegian Prescription Database and Patient Register.The Safety of Melatonin in Humans.Sleep in Children with Autism Spectrum Disorder.Psychopharmacological interventions in autism spectrum disorder.Sleep Problems as Consequence, Contributor, and Comorbidity: Introduction to the Special Issue on Sleep, Published in Coordination With Special Issues in Clinical Practice in Pediatric Psychology and Journal of Developmental and Behavioral PediatricAssessment of Sleep in Children with Autism Spectrum Disorder.Links between sleep and daytime behaviour problems in children with Down syndrome.The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder.Hyperactivity and male-specific sleep deficits in the 16p11.2 deletion mouse model of autism.What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.Meta-analysing the effectiveness of melatonin for sleep-disturbed individuals with autism spectrum conditions: should Rett syndrome be included?Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial.
P2860
Q21296744-F3952418-CFEE-492E-8F8A-03E59C92F4E0Q24603000-45B0CFF5-8CFF-4F9B-BA2C-2D9A5B97D123Q24612945-0575B1A7-78E6-4B3E-83B3-4D57A898FECBQ27012836-0CB24D97-5B35-4261-8472-FB7E8220DA23Q28080719-03124436-DDBE-4ED2-9AE6-792A2B01A17CQ28661706-FA79B947-E114-4639-BB23-2847E263E286Q30436298-D33A40E4-3E26-4F71-9948-24B86F92CF99Q30544948-163FC949-533E-4AD5-910A-8E2A048B73F7Q33616780-23A13611-6B54-4920-8460-98FFC2D4111AQ33704992-9BC42289-6D40-43D7-9B09-90325759032DQ33832237-BF1B3214-4C75-4FF7-AD14-AC5B4CD28462Q34257621-67CB312D-851E-48FA-8817-A7F3EE013C88Q34270618-0D3D0E1A-91E9-4637-AE15-3241A35F6CE5Q34500373-AF341D62-5F03-43CD-A0F2-5CFEA4540088Q34658005-CE0F2A0F-11A8-46F9-A076-1D9EFA3C2C93Q35754133-19D62620-9EB6-4179-8DF8-E5EB4BA05257Q36026077-E200862D-379C-4B9C-BBF7-609A622F531AQ36090692-9576AA15-B8AE-47D4-9536-2E47FD750418Q36189519-2CB92860-619F-4036-AB4E-CB7560B6BF33Q36654651-B551950A-DF00-489F-A531-B82FC57021D4Q36735320-B688EAC5-9104-4E85-AF4D-30C7C5F83E40Q37299857-95DF7933-F6B6-4674-945E-6B62A9B65CEEQ38107509-93213BB7-29F9-4683-B031-D43F801226FFQ38193069-1B03AF23-CA2B-4FB3-A2C8-976EDF31EE56Q38429055-A0B17CB0-A330-4A46-B6D8-7B4DFD13F304Q38675828-0C6BBCD9-F8EA-42EB-B9C0-55ABB0B89F38Q38684197-57E62654-5F69-41BA-B0DD-8A80B7EF1EB6Q38739577-C1A8CDBD-F67F-4B26-82C0-53C94F46D892Q38866034-3EB15579-C813-46B7-9E1C-E6FEFBE2B142Q41552545-DB0F79CB-F62A-41AD-A857-9A7212C3E732Q47184233-427D5B48-09E0-4031-BD7E-571480B97FC5Q47551499-3071C0B9-AE68-4581-A76C-3042FCD211A7Q47807134-D5D857FB-81E4-4B4D-B050-C8D5461091C8Q47812079-E29AB94E-6807-4C38-9D77-428D699EA06EQ47975631-442D2A29-DCEB-4CDA-8A11-340D91805311Q48243417-8070902E-37FF-450E-9E45-63ABEC208D39Q48288602-A832C87D-EEFE-42B8-88FB-D13F8ECD9D1AQ49425150-9A5FAE46-755A-44D4-A2D1-8944B53B431E
P2860
Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@ast
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@en
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@nl
type
label
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@ast
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@en
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@nl
prefLabel
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@ast
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@en
Melatonin versus placebo in ch ...... ed controlled crossover trial.
@nl
P2093
P2860
P921
P1476
Melatonin versus placebo in ch ...... sed controlled crossover trial
@en
P2093
Ahmed Alwazeer
Barry Wright
Ben Alderson-Day
Charlotte Leyland
Christine Jakeman
Clare Whitton
David Sims
Heather Tomlinson
Jenni Jardine
Jeremy Miles
P2860
P2888
P304
P356
10.1007/S10803-010-1036-5
P407
P577
2011-02-01T00:00:00Z
P6179
1023672754